Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610618-21-000093
Filing Date
2021-10-04
Accepted
2021-10-04 21:31:08
Documents
1
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163339744924025.html 4  
1 FORM 4 wf-form4_163339744924025.xml 4 3508
  Complete submission text file 0001610618-21-000093.txt   4995
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6310 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Sandison Taylor (Reporting) CIK: 0001702287 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36912 | Film No.: 211304992